Literature DB >> 17101663

Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis.

Ruth R Montgomery1, Carmen J Booth, Xiaomei Wang, Victoria A Blaho, Stephen E Malawista, Charles R Brown.   

Abstract

Lyme arthritis, caused by the spirochete Borrelia burgdorferi, can be recurrent or prolonged, whereas Lyme carditis is mostly nonrecurring. A prominent difference between arthritis and carditis is the differential representation of phagocytes in these lesions: polymorphonuclear leukocytes (PMN) are more prevalent in the joint, and macrophages predominate in the heart lesion. We have previously shown differential efficiency of B. burgdorferi clearance by PMN and macrophages, and we now investigate whether these functional differences at the cellular level may contribute to the observed differences in organ-specific pathogenesis. When we infected mice lacking the neutrophil chemokine receptor (CXCR2(-/-) mice) with spirochetes, we detected fewer PMN in joints and less-severe arthritis. Here we have investigated the effects of the absence of the macrophage chemokine receptor CCR2 on the development and resolution of Lyme carditis in resistant (C57BL/6J [B6]) and sensitive (C3H/HeJ [C3H]) strains of mice. In B6 CCR2(-/-) mice, although inflammation in hearts is mild, we detected an increased burden of B. burgdorferi compared to that in wild-type (WT) mice, suggesting reduced clearance in the absence of macrophages. In contrast, C3H CCR2(-/-) mice have severe inflammation but a decreased B. burgdorferi burden compared to that in WT C3H mice both at peak disease and during resolution. Histopathologic examination of infected hearts revealed that infected C3H CCR2(-/-) animals have an increased presence of PMN, suggesting compensatory mechanisms of B. burgdorferi clearance in the hearts of infected C3H CCR2(-/-) mice. The more efficient clearance of B. burgdorferi from hearts by CCR2(-/-) versus WT C3H mice suggests a natural defect in the recruitment or function of macrophages in C3H mice, which may contribute to the sensitivity of this strain to B. burgdorferi infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101663      PMCID: PMC1828503          DOI: 10.1128/IAI.00685-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection.

Authors:  T R Traynor; W A Kuziel; G B Toews; G B Huffnagle
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis.

Authors:  K Fuse; M Kodama; H Hanawa; Y Okura; M Ito; T Shiono; S Maruyama; S Hirono; K Kato; K Watanabe; Y Aizawa
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

Review 3.  Analysis of the lysosomal storage disease Chediak-Higashi syndrome.

Authors:  D M Ward; G M Griffiths; J C Stinchcombe; J Kaplan
Journal:  Traffic       Date:  2000-11       Impact factor: 6.215

Review 4.  Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix.

Authors:  G G Vaday; S Franitza; H Schor; I Hecht; A Brill; L Cahalon; R Hershkoviz; O Lider
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

5.  Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice.

Authors:  G Wang; C Ojaimi; R Iyer; V Saksenberg; S A McClain; G P Wormser; I Schwartz
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Borrelia burgdorferi are susceptible to killing by a variety of human polymorphonuclear leukocyte components.

Authors:  Denise Lusitani; Stephen E Malawista; Ruth R Montgomery
Journal:  J Infect Dis       Date:  2002-02-20       Impact factor: 5.226

7.  Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun.

Authors:  C Georganas; H Liu; H Perlman; A Hoffmann; B Thimmapaya; R M Pope
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

8.  Murine Lyme disease: no evidence for active immune down-regulation in resolving or subclinical infection.

Authors:  R R Montgomery; X M Wang; S E Malawista
Journal:  J Infect Dis       Date:  2001-04-23       Impact factor: 5.226

9.  Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues.

Authors:  L Yang; J H Weis; E Eichwald; C P Kolbert; D H Persing; J J Weis
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation.

Authors:  N Sato; S K Ahuja; M Quinones; V Kostecki; R L Reddick; P C Melby; W A Kuziel; S S Ahuja
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  28 in total

1.  Macrophage Polarization during Murine Lyme Borreliosis.

Authors:  Carrie E Lasky; Rachel M Olson; Charles R Brown
Journal:  Infect Immun       Date:  2015-04-13       Impact factor: 3.441

2.  CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of lyme arthritis.

Authors:  Bikash Sahay; Anju Singh; Arumugam Gnanamani; Rebeca L Patsey; J Edwin Blalock; Timothy J Sellati
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Inhibition of neutrophil function by two tick salivary proteins.

Authors:  Xiuyang Guo; Carmen J Booth; Michael A Paley; Xiaomei Wang; Kathleen DePonte; Erol Fikrig; Sukanya Narasimhan; Ruth R Montgomery
Journal:  Infect Immun       Date:  2009-03-30       Impact factor: 3.441

Review 4.  Macrophage diversity in cardiac inflammation: a review.

Authors:  Jobert G Barin; Noel R Rose; Daniela Ciháková
Journal:  Immunobiology       Date:  2011-06-30       Impact factor: 3.144

5.  Outer surface protein OspC is an antiphagocytic factor that protects Borrelia burgdorferi from phagocytosis by macrophages.

Authors:  Sebastian E Carrasco; Bryan Troxell; Youyun Yang; Stephanie L Brandt; Hongxia Li; George E Sandusky; Keith W Condon; C Henrique Serezani; X Frank Yang
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

6.  A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.

Authors:  Ye Zhang; Melissa A Cobleigh; Jian-Qi Lian; Chang-Xing Huang; Carmen J Booth; Xue-Fan Bai; Michael D Robek
Journal:  Gastroenterology       Date:  2011-06-25       Impact factor: 22.682

7.  Interferon-γ influences the composition of leukocytic infiltrates in murine lyme carditis.

Authors:  Gregory J Sabino; Sonya J Hwang; Shane C McAllister; Patricio Mena; Martha B Furie
Journal:  Am J Pathol       Date:  2011-08-05       Impact factor: 4.307

8.  A protective function for interleukin 17A in T cell-mediated intestinal inflammation.

Authors:  William O'Connor; Masahito Kamanaka; Carmen J Booth; Terrence Town; Susumu Nakae; Yoichiro Iwakura; Jay K Kolls; Richard A Flavell
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

9.  Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis.

Authors:  Ashish V Chintakuntlawar; James Chodosh
Journal:  J Interferon Cytokine Res       Date:  2009-10       Impact factor: 2.607

10.  Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta.

Authors:  Juan C Salazar; Star Duhnam-Ems; Carson La Vake; Adriana R Cruz; Meagan W Moore; Melissa J Caimano; Leonor Velez-Climent; Jonathan Shupe; Winfried Krueger; Justin D Radolf
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.